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The RIG-I/Mda5 sensors recognize viral intracellular
RNA and trigger host antiviral responses. RIG-I
signals through the adaptor protein MAVS, which
engages various TRAF family members and results
in type I interferon (IFNs) and proinflammatory cyto-
kine production via activation of IRFs and NF-kB,
respectively. Both the IRF and NF-kB pathways also
require the adaptor protein NEMO. We determined
that the RIG-I pathway is differentially regulated by
the linear ubiquitin assembly complex (LUBAC),
which consists of the E3 ligases HOIL-1L, HOIP, and
the accessory protein SHARPIN. LUBAC downregu-
lated virus-mediated IFN induction by targeting
NEMO for linear ubiquitination. Linear ubiquitinated
NEMO associated with TRAF3 and disrupted the
MAVS-TRAF3 complex, which inhibited IFN activa-
tion while stimulating NF-kB-dependent signaling.
In SHARPIN-deficient MEFs, vesicular stomatitis
virus replication was decreased due to increased
IFN production. Linear ubiquitination thus switches
NEMO from a positive to a negative regulator of
RIG-I signaling, resulting in an attenuated IFN
response.
INTRODUCTION
The innate immune response represents the first line of defense
against microbial pathogens and results in the production of
immunomodulatory cytokines and the mobilization of innate
immune cells. Central to the early host defense against viral
infection is the production of interferons (IFN) and the synthesis
of antiviral IFN stimulated genes (ISGs) that contain virus dissem-
ination and activate the adaptive immune response (Liu et al.,
2011; Sadler and Williams, 2008; Sen and Sarkar, 2007). ViralCell Hosnucleic acids represent pathogen-associated molecular
patterns (PAMPs) that are recognized by pattern recognition
receptors (PRRs) to trigger the type I IFN—IFNa and IFNb—
production (Belgnaoui et al., 2011; Loo andGale, 2011; Takeuchi
and Akira, 2010; Yoneyama and Fujita, 2010). PRRs responsible
for the detection of RNA viruses (and some DNA viruses) include
both the membrane-bound Toll-like receptors (TLRs) and cyto-
solic sensors, such as retinoic acid-inducible gene-I (RIG-I)-like
receptors (RLRs) (Belgnaoui et al., 2011; Beutler, 2009; Kumar
et al., 2011; Loo and Gale, 2011; Takeuchi and Akira, 2010;
Wilkins and Gale, 2010; Yoneyama and Fujita, 2010).
Early viral RNA replicative intermediates are mainly detected
by RIG-I or Mda5 (melanoma differentiation-associated gene
5)—two characterized cytosolic viral RNA receptors belonging
to the DExD/H box RNA helicase family (Kato et al., 2006;
Yoneyama et al., 2004). The functions of RIG-I and Mda5 are
nonredundant as RIG-I specifically detects intracellular double-
stranded (ds) viral RNA bearing 50 triphosphate and panhandle
structures (Rehwinkel et al., 2010; Schlee and Hartmann, 2010;
Schlee et al., 2009; Yoneyama and Fujita, 2008), leading to
RIG-I interaction with the downstream adaptor protein MAVS
(also known as Cardif/IPS-1/VISA) (Kawai et al., 2005; Meylan
et al., 2005; Seth et al., 2005; Xu et al., 2005); Mda5 recognizes
dsRNA structures such as synthetic poly (I:C) (>2 kb) and also
signals through MAVS. Strategically localized at the outer
mitochondrial membrane or on peroxisomes, MAVS assembles
a signaling platform that triggers the IFN antiviral response, via
activation of the transcription factors NF-kB and IFN regulator
factors (IRF)-3 and -7 (Belgnaoui et al., 2011; Dixit et al., 2010;
Scott, 2010). Crucial to MAVS complex formation and down-
stream signaling is the recruitment of the tumor necrosis
ractor (TNF) receptor-associated factors (TRAFs), a family of
cytoplasmic signaling adaptor proteins (Ha¨cker et al., 2011).
Several TRAF family members—TRAF-2, -3, -5 and -6—directly
bind to MAVS via TRAF-interacting motifs (TIM) in the N- and
C-terminal regions of MAVS (Paz et al., 2011; Saha et al.,
2006; Tang and Wang, 2010; Xu et al., 2005). Interaction of
MAVS with TRAF-2 or -6 is involved in IKK-dependent NF-kB
activation (Xu et al., 2005), whereas TRAF3 is specificallyt & Microbe 12, 211–222, August 16, 2012 ª2012 Elsevier Inc. 211
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2011; Saha et al., 2006).
In addition to the adapters, kinases, and accessory proteins of
the MAVS complex, the NF-kB modulator protein NEMO (IKKg)
also interfaces with the RIG-I pathway and forms a regulatory
bridge between the canonical IKKa/b kinases and the noncanon-
ical kinases TBK1/IKKε via the TANK adaptor (Chariot et al.,
2002; Zhao et al., 2007). NEMO activity is regulated by numerous
posttranslational modifications, including ubiquitination, phos-
phorylation, and sumoylation (Liu and Chen, 2011; Sebban
et al., 2006). Multiple ubiquitination signals have been identi-
fied—mono-, multiple- or polyubiquitination—that control pro-
tein fate and turnover (Bhoj and Chen, 2009; Dikic and Do¨tsch,
2009; Ikeda et al., 2010; Kirisako et al., 2006; Malynn and
Ma, 2010; Weissman et al., 2011). Lys48 and Lys63 linkages
are the best characterized types of polyubiquitination, with
Lys48-linked polyubiquitination leading to ubiquitin-dependent
degradation by the 26S proteasome (Dikic and Do¨tsch, 2009;
Gallastegui and Groll, 2010). In contrast, Lys63-linked ubiquiti-
nation is associated with activation of protein kinases, protein-
protein interactions, DNA repair, and endocytosis (Bergink and
Jentsch, 2009; Bhoj and Chen, 2009).
Recently, another form of polyubiquitin chain formation was
identified in association with NEMO; unlike Lys63- or Lys48-
linked polyubiquitin chains that link ubiquitin moieties via a lysine
residue of the previously attached ubiquitin, linear ubiquitination
consists of head-to-tail linked ubiquitin moieties (Tokunaga
et al., 2009). Upon TNFa stimulation, the E3 ligase linear ubiquitin
chain assembly complex (LUBAC), composed of the two RING-
IBR-RING (RBR)-containing E3 ligases, HOIL-1L (also known
as RBCK1 and RNF54) and HOIP (also known as ZIBRA and
RNF31), mediates the formation of linear ubiquitin chains on
NEMO (Tokunaga et al., 2009), which functions to activate
NF-kB signaling downstream of the TNF receptor. LUBAC
activity is also dependent on a third accessory protein SHANK-
associated RH domain interactor (SHARPIN) that stabilizes the
E3 complex (Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga
et al., 2011).
Linear ubiquitination also modulates the RIG-I antiviral
pathway but has not been reported to affect the Mda5 receptor.
TRIM25, an E3 ligase that regulates RIG-I activation via Lys63-
linked ubiquitination (Gack et al., 2007), was characterized as
a unique target of the LUBAC complex (Inn et al., 2011), with
linear ubiquitination of TRIM25 resulting in its proteasomal
degradation. HOIL-1L or HOIP independently mediated Lys48-
linked polyubiquitination and proteasomal degradation of
TRIM25 (Inn et al., 2011).
In the present study, we demonstrate that the LUBAC complex
contributes to negative regulation of the type I IFN response via
linear ubiquitination of NEMO. Using chimeric forms of NEMO,
modified by the addition of different linear ubiquitin moieties,
we demonstrate that NEMO-Ub with two or more linear ubiquitin
moieties, but not unmodified NEMO, bound to TRAF3 and
dissociated the MAVS-TRAF3 complex. Furthermore, in
SHARPIN-deficient cpdm mouse embryonic fibroblasts (MEFs),
vesicular stomatitis virus (VSV) replication is decreased and the
IFN antiviral response increased, highlighting the crucial role of
linear ubiquitination in the negative regulation of the antiviral
response.212 Cell Host & Microbe 12, 211–222, August 16, 2012 ª2012 ElseviRESULTS
LUBAC Inhibits the IFN Antiviral Response Downstream
of the Adaptor MAVS
To examine the effect of linear ubiquitination on the antiviral
response, LUBACwas coexpressed in HEK293 cells in the pres-
ence of NF-kB and IFN-stimulated response element (ISRE)
reporter genes. LUBAC activated the NF-kB promoter more
than 50-fold but inhibited Sendai virus (SeV)-mediated activa-
tion of the ISRE promoter by 3-fold (Figure 1A). To determine
at what level in the pathway LUBAC blocked ISRE expression,
the active CARD domain containing form of RIG-I (DRIG-I)
(Yoneyama et al., 2004), the Mda5 sensor, MAVS, TBK1 kinase,
or the active form of IRF-3 (IRF-3[5D]) were expressed in the
presence or absence of LUBAC. All expression constructs re-
sulted in a 300- to 1000-fold induction of ISRE-Luc reporter
activity (Figure 1B; white bar). ISRE activation driven by Mda5,
DRIG-I, or MAVS was inhibited more than 85% by LUBAC,
whereas ISRE induction by TBK1 or IRF-3(5D) was not affected
by LUBAC coexpression (Figure 1B; compare black to white
bars). The same expression constructs also induced ISG15
protein expression (Figure 1C; compare lanes 3, 5, 7, 9, and
11), and the addition of LUBAC inhibited ISG15 induction by
Mda5, DRIG-I, or MAVS (Figure 1C; lanes 4, 6, and 8), but not
by TBK1 or IRF-3 (5D) (Figure 1C, lanes 10 and 12). To confirm
the inhibitory effect of LUBAC on IFN signaling, expression of
HOIL-1L was knocked down by small-interfering RNA (siRNA)
in A549 cells, followed by SeV challenge for 4, 8 and 12 hr.
IRF-3 phosphorylation (4 hr) and subsequent degradation
(12 hr) was increased in cells with decreased levels of HOIL-
1L (Figure 1D). Inhibition of HOIL-1L expression also led to an
increase in ISRE promoter activation by Mda5, DRIG-I, or
MAVS, but not by TBK1 or IRF-3 (5D) (Figure 1E). Similar exper-
iments using the TLR3 and TLR4 adaptor protein TRIF demon-
strated that LUBAC did not affect MAVS-independent ISRE
promoter activation (data not shown). These results indicate
that LUBAC inhibits the IFN antiviral response downstream of
MAVS and upstream of TBK1.
Linear Ubiquitination of NEMO Inhibits IFN Induction
The association of the IKK adaptor NEMO and the TBK1 adaptor
TANK coordinately regulates NF-kB and IRF-3 signaling down-
stream of RIG-I (Chariot et al., 2002; Zhao et al., 2007). To inves-
tigate whether LUBAC-mediated linear ubiquitination of NEMO
was involved in the control of type I IFN signaling, we generated
NEMO chimeric constructs fused at their C terminus with linear
ubiquitin chains of variable sizes, consisting of one, two, or four
linear ubiquitin moieties, termed NEMO-Ub1, NEMO-Ub2, and
NEMO-Ub4, respectively. The different NEMO-Ub chimeras
stimulated NF-kB reporter gene activity without any additional
stimulation, whereas unmodified wild-type NEMO (WT-NEMO)
failed to activate the NF-kB reporter gene (Figure 2A). When the
chimeric constructs were tested with the ISRE promoter
after SeV infection or expression of Mda5, DRIG-I, MAVS,
TBK1, or IRF-3(5D), neither WT-NEMO nor NEMO-Ub chimeras
activated the ISRE promoter alone; in contrast, NEMO-Ub2 and
NEMO-Ub4 inhibited SeV, Mda5, DRIG-I, or MAVS-driven
promoter activity by >75%, compared to WT-NEMO or NEMO-
Ub1 (Figures 2B and 2C). Similar to the results obtained wither Inc.
Figure 1. LUBAC Inhibits the IFN Response Downstream of MAVS
(A) HEK293 cells were transfected with either the NF-kB-Luc or ISRE-Luc promoter along with empty vector or LUBAC and were left untreated or challenged
with SeV for 16 hr. Luciferase activity was analyzed at 24 hr posttransfection and fold activation was determined compared to empty vector; values represent
the average ± SD. Results are representative of at least three experiments run in triplicate.
(B) HEK293 were challenged with either SeV or the following activators encoding, Mda5 (200 ng), DRIG-I (200 ng), MAVS (50 ng), TRIF (50 ng), TBK1 (50 ng),
or IRF-3 (5D) (50 ng), along with either empty vector () or LUBAC (400 ng) and the ISRE-Luc reporter plasmids. Luciferase activity and analysis was performed
as in (A).
(C) HEK293 were transfected with empty vector (), GFP-Mda5, GFP-DRIG-I, GFP-MAVS, GFP-TBK1, or GFP-IRF-3(5D), with or without LUBAC. Whole-cell
lysates were subjected to immunoblot analysis and blotted with anti ISG15 (top panel), anti-GFP (second panel), anti-MYC (third panel), anti-HA (fourth panel), or
anti-actin (last panel) antibodies.
(D) A549 cells transfected with either siRNA control (si control) or siRNA HOIL-1L (si HOIL-1L) then left untreated or treated with SeV for 4, 8, or 12 hr. Immunoblot
analysis was performed using either anti p-s396-IRF-3 antibody (top panel), anti-IRF3 antibody (second panel), anti-HOIL-1L antibody (third panel), or anti-actin
antibody (bottom panel).
(E) HEK293 cells were transfected with either siRNA control or siRNA against HOIL-1L. At 48 hr posttransfection, cells were again transfected with the ISRE-
Luc promoter along with empty vector or Mda5, DRIG-I, MAVS, TBK1, IRF-3(5D). Luciferase activity was monitored as in (A) and (B); values represent the
average ± SD.
Cell Host & Microbe
Linear Ubiquitinated NEMO Inhibits RIG-I SignalingLUBAC, the NEMO-Ub constructs did not inhibit TBK1- or
IRF-3(5D)-driven ISRE activity. MAVS-independent activation of
the ISRE promoter by TRIF was not affected by the different
NEMO-Ub constructs (data not shown). Furthermore, NEMO-
Ub2 inhibited expression of various ISGs—ISG15, ISG56 and
RIG-I—whereas WT-NEMO or NEMO-Ub1 had no effect on ISG
expression (Figure 2D; compare lane 5, 8, and 11—top, second,
and third panels). Interestingly, NEMO-Ub2 also failed to inhibit
ISG expression after IFNa treatment (Figure 2D; lane 12), sug-
gesting that the inhibition of the type I IFN signaling pathway
occurred at an early stage of signaling, prior to IFN release.
Linear Ubiquitinated NEMO Interacts with TRAF3
Because both TRAF3 and NEMO are positive regulators of type I
IFN signaling downstream of MAVS, we investigated the possi-Cell Hosbility that linear ubiquitination of NEMO regulated the formation
of the MAVS-TRAF3 complex. In coprecipitation experiments,
TRAF3 coprecipitated with NEMO-Ub2, weakly with NEMO-
Ub1 (Figure 3A; compare lane 4 to 3, top panel), and not with
WT-NEMO (Figure 3A; lane 2, top panel). Next, NEMO and
TRAF3 were expressed in the presence or absence of LUBAC.
NEMO alone did not interact with TRAF3, but the addition of
LUBAC led to the formation of the NEMO-TRAF3 complex (Fig-
ure 3B; compare lane 5 to 6, second panel). In the same exper-
iment, using a NEMO-specific antibody, modified forms of
NEMO were detected in the presence of LUBAC, thus suggest-
ing that linear ubiquitinated NEMO interacted with TRAF3
(Figure 3B; lane 6—top panel). To demonstrate that LUBAC E3
ligase complex formation was required for this interaction,
HOIL-1L and/or HOIP were expressed in the presence oft & Microbe 12, 211–222, August 16, 2012 ª2012 Elsevier Inc. 213
Figure 2. Linear Ubiquitination of NEMO
Inhibits IFN Induction
(A) HEK293 cells were transfected with empty
vector (), NEMO, NEMO-Ub1, NEMO-Ub2,
NEMO-Ub4, HOIL-1L, HOIP, or LUBAC along with
the NF-kB-Luc reporter plasmid. Luciferase
activity was analyzed as described in Figure 1A;
values represent the average ±SD.
(B andC) HEK293 cells were challengedwith either
SeV or the following activators—Mda5 (200 ng),
DRIG-I (200 ng), MAVS (50 ng), TRIF (50 ng), TBK1
(50 ng), or IRF-3 (5D) (50 ng)—along with either
empty vector (), NEMO-Ub1, NEMO-Ub2, or
NEMO-Ub4 (400 ng each) and the ISRE-Luc
reporter plasmids. Luciferaseactivitywasanalyzed
as in (A); values represent the average ± SD.
(D) HEK293 cells were either treated or not with
IFNa (16 hr); infected or not with SeV (12 hr); and
transfected with either empty vector (), NEMO,
NEMO-Ub1, or NEMO-Ub2. Whole-cell lysates
were subjected to immunoblot analysis using
anti-ISG56 (top panel), anti-ISG15 (second panel),
anti-RIG-I (third panel), anti-FLAG (fourth panel),
anti-SeV (fifth panel), or anti-actin (last panel)
antibodies.
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Linear Ubiquitinated NEMO Inhibits RIG-I SignalingTRAF3 and NEMO (Figure 3C). A NEMO-TRAF3 interaction was
readily detected when both LUBAC components were present,
but not when individual components were expressed (Figure 3C;
compare lane 7 to lanes 8 and 9), thus demonstrating that
NEMO-TRAF3 interaction was dependent on the presence of
the LUBAC complex.
Linear Ubiquitinated NEMO Competes with MAVS for
TRAF3 Binding
To examine whether linear ubiquitination of NEMO affected
IFN signaling at the level of MAVS-TRAF3 interaction, MAVS-
TRAF3 association was determined in the presence of LUBAC
and/or NEMO. Expression of MAVS led to an interaction
with TRAF3 (Figure 4A; lane 4); when individually expressed,
NEMO and LUBAC coexpression modestly disrupted this inter-
action by 2.4- and 1.7-fold, respectively (59% and 41%, respec-
tively) (Figure 4A; lane 5 and 7), but in the presence of both
LUBAC and NEMO, the MAVS-TRAF3 complex was decreased214 Cell Host & Microbe 12, 211–222, August 16, 2012 ª2012 Elsevier Inc.more than 5-fold (81%) (Figure 4A;
lane 8). Conversely, the LUBAC-induced
TRAF3-NEMO interaction was disrupted
in the presence of MAVS (Figure 4B;
compare lanes 8 and 9) and the recip-
rocal coprecipitation generated similar
results (Figure 4C). To determine whether
linear ubiquitinated NEMO and MAVS
compete for TRAF3 binding, NEMO
was precipitated in the presence of con-
stant amounts of LUBAC and TRAF3,
but increasing amounts of MAVS. In-
creasing MAVS disrupted the LUBAC-
induced NEMO-TRAF3 complex in a
dose-dependent manner (Figure 4D).
Taken together, these results indicatethat the MAVS-TRAF3 interaction is disrupted by linear ubiquiti-
nated NEMO.
Increased Antiviral Response and Decreased VSV
Replication in cpdm MEFs
To test the endogenous role of linear ubiquitination in the RIG-I
pathway, cpdm MEFs, deficient in the accessory protein
SHARPIN that functions to stabilize the LUBAC complex (Ger-
lach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011),
were used tomeasure replication of a recombinant VSV express-
ing green fluorescent protein (VSV-GFP) (Figure 5A). In cpdm
MEFs, at 24 and 48 hr after VSV infection, fewer cells were
positive for GFP fluorescence, compared to WT MEFs (70%
GFP-positive WT MEFs, compared to 40% GFP-positive
cpdm MEFs) (Figure 5B). Additionally, VSV replicated in cpdm
compared to WT MEFs, as reflected by VSV glycoprotein
(VSV-G) expression (Figure 5C; second panel). Furthermore, an
enhanced antiviral response was observed in cpdm MEFs
Figure 3. Linear Ubiquitinated NEMO Interacts with TRAF3
(A) HEK293 cells were transfected with FLAG-tagged TRAF3 and an empty
vector or S-tagged WT-NEMO (S-NEMO), S-NEMO-Ub1, or S-NEMO-Ub2.
S-tagged proteins were then precipitated using the S-tag purification tech-
nique and immunoblotted using anti FLAG antibody (top panel) to reveal
TRAF3 interaction. Equal pull-down of NEMO was verified using anti NEMO
antibody (second panel). Whole-cell lysates were subjected to immunoblot
analysis using anti FLAG (third panel, TRAF3), anti-NEMO (fourth panel) or anti-
actin (last panel) antibodies.
(B) HEK293 cells were transfected with S-NEMO, FLAG-TRAF3, S-NEMO,
and FLAG-TRAF3 or S-NEMO and FLAG-TRAF3 in combination with HOIL-1L
and HOIP (LUBAC). S-NEMO was pulled down as in (A) and immunoblotted
using anti-NEMO (first panel, pull-down control) or anti-FLAG (second panel,
TRAF3 interaction). Whole-cell lysates were subjected to immunoblot analysis
using anti FLAG (third panel, TRAF3), anti-NEMO (fourth panel), anti-MYC
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Cell Hoscompared to WT MEFs following VSV infection, as reflected by
an increase in IFNb promoter activity (200-fold induction in
WT MEFs compared to 600-fold increase in cpdm MEFs) and
IFNa4 promoter (50-fold induction in WT MEFs compared to
250-fold in cpdm MEFs) (Figure 5D). RIG-I protein expression
was also increased in cpdm MEFs, thus demonstrating
a stronger induction of IFN production (Figure 5C; top panel).
Because NF-kB activation by TNFa was shown to be impaired
in cpdmMEFs (Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga
et al., 2011), we also examined whether NF-kB activation was
defective in the context of VSV infection. NF-kB and IL6
promoter activation were attenuated in cpdm MEFs after VSV
infection (from 20-fold to 5-fold and from 9-fold to
3-fold respectively) (Figure 5E). Because SHARPIN was shown
to have an antiapoptotic role upon TNFa activation (Gerlach
et al., 2011; Ikeda et al., 2011), the level of apoptosis in WT
and cpdmMEFs was assessed after virus infection. An increase
in apoptosis, as measured by Annexin V/ propidium iodide (PI)
positive cells (45% in cpdm MEFs compared to 15% in WT
MEFs), and an accumulation of cleaved caspase 3 in cpdm
compared to WT MEFs were detected (Figures 5F and 5G),
demonstrating that SHARPIN deficiency rendered the cells
more sensitive to virus-induced cell death.
Linear Ubiquitinated NEMO Interacts with TRAF3
and Dissociates the MAVS-TRAF3 Complex
Next, using a linear ubiquitin chain-specific antibody (Tokunaga
et al., 2009), we demonstrated that endogenous NEMO was
targeted for linear ubiquitination after VSV infection (Figure 6A).
In WT MEFs, NEMO was linearly ubiquitinated 48 hr after infec-
tion (Figure 6A; top panel, lane 5), concomitant with its interac-
tion with TRAF3 (Figure 6A; second panel, lane 5). In contrast,
NEMO did not undergo linear ubiquitination in cpdm MEFs and
did not bind TRAF3 (Figure 6A; lanes 6–10, top and second
panels). The reciprocal coimmunoprecipiation experiment in
which TRAF3 was immunoprecipitated confirmed the strong
interaction between TRAF3 and NEMO at 48 hr in WT MEFs
(Figure 6B). This association was decreased by more than
6-fold in cpdm MEFs, indicating that TRAF3-NEMO association
was enhanced in a linear ubiquitin-dependentmanner (Figure 6B;
compare lane 5 to 10). In parallel, an increased association of
MAVS-TRAF3 was observed in cpdm MEFs compared to WT
MEFs, particularly at 48 hr after infection (5-fold increase) (Fig-
ure 6C; compare lane 5 to 10), arguing that linearly ubiquitinated
NEMOdislodges TRAF3 fromMAVS by physical interaction. This
dissociation from MAVS did not occur when NEMO was not
linearly ubiquitinated.
The expression of antiviral IFN stimulated genes—IRF7,
DDX58 (RIG-I), and OAS1—were also highly induced in cpdm
MEFs (Figure 7A; black bars) after virus infection, compared to
WT MEFs (white bars), due to intact signaling as a consequence(fourth panel, HOIL-1L), anti-HA (fifth panel, HOIP) or anti-actin (last panel)
antibodies.
(C) HEK293 cells were transfected with S-NEMO, FLAG-TRAF3, S-NEMO, and
FLAG-TRAF3 or S-NEMO and FLAG-TRAF3 in combination with HOIL-1L
alone, HOIP alone, or with both (LUBAC). S-NEMO was pulled down and
immunoblotted as in (B). Whole-cell lysates were subjected to immunoblot
analysis using the same antibodies as in (B).
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Figure 4. Linear Ubiquitinated NEMO Competes with MAVS for TRAF3 Binding
(A and B) HEK293 cells were transfected with MYC-MAVS, S-NEMO, FLAG-TRAF3, HA-HOIL-1L, MYC-HOIP in combination or alone. FLAG-TRAF3 was
immunoprecipitated using an anti-FLAG antibody and subjected to immunoblot analysis using an anti-MYC antibody (A) to detect MAVS interaction (top panel) or
anti-NEMO (B) (top panel). FLAG antibody was used to probe for immunoprecipitated TRAF3 (second panel). Whole-cell lysates were subjected to immunoblot
analysis using anti-MYC (MAVS and HOIP), anti-NEMO, anti-HA (HOIL-1L), anti-FLAG (TRAF3), and anti-actin (eighth panel) antibodies.
(C) HEK293 cells were transfected with MYC-MAVS, S-NEMO, FLAG-TRAF3, and LUBAC in combination or alone. S-NEMO was precipitated and immunoblot
analysis was performed using FLAG antibody to detect TRAF3 interaction (top panel). Precipitated NEMO was revealed using anti-NEMO antibody (second
panel). Whole-cell lysates were subjected to immunoblot analysis using anti-FLAG (third panel, TRAF3), anti-NEMO (fourth panel), and anti-MYC (fifth panel,
MAVS; and seventh panel, HOIP), anti-HA (sixth panel, HOIL-1L), and anti-actin (eighth panel) antibodies.
(D) HEK293 cells were transfected with S-NEMO, FLAG-TRAF3, and LUBAC with an increasing amount of MYC-MAVS. S-NEMO was precipitated and
immunoblot analysis was performed using FLAG antibody to detect TRAF3 interaction (top panel). Precipitated NEMO was revealed using anti-NEMO antibody
(second panel). Immunoblots using anti-FLAG (third panel, TRAF3), anti-MYC (fourth panel, MAVS and HOIP), anti-HA (fifth panel, HOIL-1L), anti-NEMO (sixth
panel), and anti-actin (seventh panel) antibodies.
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IRF7 mRNA levels peaked at 150-fold in cpdm MEFs com-
pared to 15-fold in WT MEFs; similarly, DDX58 peaked at
13-fold and OAS1 peaked at 250-fold; the values in WT
MEFs were 3-fold and 30-fold, respectively. By ELISA, a
3-fold increase in IFNa and IFNb release into the supernatant
of cpdm cells was detected compared to WT MEFs (Figure 7B).
Strikingly, VSV infection of cpdm MEFs failed to induce IL6 pro-
moter (Figure 7C; black bars), illustrating the functional impact of
NF-kB inhibition on inflammatory cytokine gene expression. IL6
release post-VSV infection was also 3-fold lower in cpdm com-
pared to WT MEFs (Figure 7D). Altogether, these results demon-216 Cell Host & Microbe 12, 211–222, August 16, 2012 ª2012 Elsevistrate that linear ubiquitination of NEMO following virus infection
facilitates the formation of a NEMO-TRAF3 heterodimer;
sequestration of TRAF3 away from the MAVS complex contrib-
utes to the termination of RIG-I dependent signaling (Figure 7E).
Linear ubiquitination of NEMO thus negatively regulates pro-
duction of type I IFN and multiple ISGs, while positively regu-
lating activation of NF-kB and inflammatory gene expression.
DISCUSSION
In the present study, we demonstrate an essential role
for LUBAC-mediated linear ubiquitination of NEMO in theer Inc.
Figure 5. Increased Antiviral Response and Decreased VSV Replication in cpdm MEFs
(A) VSV-GFP infection was assessed using flow cytometry in cpdm and WT MEFs 24 hr following virus infection with different MOIs (0, 0.01, 0.1, 1, and 10). The
histogram represents GFP expression in WT and cpdm MEFs at 10 MOI. Two-way ANOVA p < 0.0001; values represent the average ± SEM.
(B) Fluorescent (top panel) and phase contrast microscopy (bottom panel) of WT and cpdmMEFs infected with VSV-GFP at 10 MOI for 24 hr (magnification320)
or 48 hr (magnification 310).
(C) WT and cpdmMEFs were infected with VSV (10 MOI) for the indicated times. Whole-cell lysates were subjected to immunoblot analysis using anti-RIG-I (top
panel), anti-VSV (second panel), anti-SHARPIN (third panel), and anti-actin (bottom panel) antibodies.
(D and E) WT and cpdm MEFs were transfected with the IFNb, IFNa4 + IRF7, IL6, or NF-kB reporter and infected with VSV at 8 hr posttransfection. Luciferase
activity was analyzed at 24 hr posttransfection and fold activation was determined compared to empty vector; values represent the average ± SD.
(F) WT and cpdm MEFs infected with VSV-GFP with the indicated MOI for 24 hr or 48 hr. Apoptosis was measured by flow cytometry by Annexin V/PI staining;
values represent the average ± SEM.
(G) WT and cpdm MEFs were infected with VSV (10 MOI) for the indicated times. Whole-cell lysates were subjected to immunoblot analysis using anti-cleaved
caspase 3 (top panel), anti-SHARPIN (second panel) and anti-actin (bottom panel) antibodies.
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sequestration of TRAF3 from the MAVS adaptor. LUBAC and
NEMO-Ub constructs inhibited RIG-I signaling downstream of
MAVS and upstream of TBK1; linearly ubiquitinated NEMO
interacted physically with TRAF3 and disrupted the MAVS-
TRAF3 complex, thus providing a mechanistic explanation for
the downregulation of RIG-I signaling. Using SHARPIN-deficient
cpdm MEFs, we observed, on the one hand, an increased
and prolonged antiviral response, while on the other hand,Cell Hosan impaired NF-kB activation, indicating that linear ubiquiti-
nation is required for NF-kB activation downstream of RIG-I.
Interestingly, an increase in apoptotic cell death was also de-
tected in SHARPIN-deficient cpdm MEFs after VSV infection,
potentially attributable to the absence of the antiapoptotic
activity of NF-kB.
These studies reveal a negative feedback mechanism used by
host cells to regulate the IFN antiviral response. The formation of
the MAVS-TRAF3 complex is a crucial step of the IFN responset & Microbe 12, 211–222, August 16, 2012 ª2012 Elsevier Inc. 217
Figure 6. Linear Ubiquitinated NEMO Interacts with TRAF3 and Dissociates MAVS-TRAF3
(A) WT and cpdmMEFs were infected with VSV (10MOI) for the indicated times. Endogenous NEMOwas immunoprecipitated using an anti-NEMO antibody, and
its linear ubiquitination status as well as its ability to interact with TRAF3 was assessed using anti-linear ubiquitin (top panel) and anti-TRAF3 (second panel)
antibodies. Equal amounts of immunoprecipitated NEMOwere revealed using an anti-NEMO antibody (third panel). Input amounts for NEMO, TRAF3, SHARPIN,
and actin are shown (last four panels).
(B) WT and cpdmMEFswere infected with VSV (10MOI) for the indicated times. Endogenous TRAF3was immunoprecipitated using an anti-TRAF3 antibody, and
its ability to interact with NEMOwas assessed using anti-NEMO antibody (top panel). Equal amounts of immunoprecipitated TRAF3 were revealed using an anti-
TRAF3 antibody (second panel). Input for NEMO, TRAF3, SHARPIN, and actin are shown (last four panels).
(C) WT and cpdmMEFs were infected with VSV (10 MOI) for the indicated times. Endogenous MAVS was immunoprecipitated using an anti-MAVS antibody, and
its ability to interact with TRAF3 was assessed using anti-TRAF3 antibody (top panel). Equal amounts of immunoprecipitated MAVS were revealed using an anti-
MAVS antibody (second panel). Input amounts for TRAF3, MAVS, SHARPIN, and actin are shown (last four panels).
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as bridging adaptor in the assembly of the active MAVS-
TRAF3-TBK1 signaling complex that also includes NEMO (Paz
et al., 2011; Zeng et al., 2010). Previously, we demonstrated
the positive regulatory role of NEMO as a bridge between the
canonical IKKa/b kinases and the noncanonical kinases TBK1/
IKKε via the TANK adaptor (Zhao et al., 2007). Here, we show
that at 24–48 hr postinfection, linear ubiquitination of NEMO by
LUBAC facilitates its interaction with TRAF3, an association
that sequesters TRAF3 away from MAVS (Figure 7E). Linear
ubiquitination thus switches NEMO from a positive mediator of
RIG-I signaling to a negative regulator that dissociates the
antiviral signaling complex through a competition mechanism.
There are several possibilities that may explain the increased
ability of linear ubiquitinated NEMO to dissociate TRAF3 from
MAVS, including a direct binding of TRAF3 to linear ubiquitin218 Cell Host & Microbe 12, 211–222, August 16, 2012 ª2012 Elsevichains or a high affinity of TRAF3 for the conformationally altered
form of NEMO.
Regulation of RIG-I signaling through ubiquitination has been
extensively studied. TRIM25 and RNF135 (REUL) activate the
pathway by mediating Lys63-linked polyubiquitination of RIG-I
(Gack et al., 2007; Oshiumi et al., 2010). Conversely, inhibition
of the pathway is achieved through the Lys48-linked polyubiqui-
tination and subsequent proteasomal degradation of RIG-I
and MAVS by RNF125, and TRAF3 by Triad3A (Arimoto et al.,
2007; Nakhaei et al., 2009). The ubiquitin-editing protein A20
and several deubiquitinases such as DUBA, OTUB, and CYLD
also negatively regulate RIG-I signaling (Kayagaki et al., 2007;
Li et al., 2010; Lin et al., 2006; Wertz et al., 2004; Zhang et al.,
2008b); CYLD was shown to inhibit RIG-I signaling by removing
Lys63-linked ubiquitin chains from both RIG-I and TBK1 (Zhang
et al., 2008b), while DUBA inhibits the pathway by cleavinger Inc.
Figure 7. Increased IFN Response following Virus Infection in cpdm MEFs
(A–D) qPCR analysis of total RNA isolated from WT and cpdm MEF cells. Relative fold-expression levels of IRF7, DDX58 (RIG-I), OAS1 (A), and IL6 (C) versus
GAPDHmRNA are shown. Data are representative of at least two experiments run in duplicate; values represent the average ± SD. In (B) and (D), ELISA of IFNa,
IFNb B), and IL6 (D) in the supernatant of WT and cpdm MEFs infected with VSV at 10 MOI for 48 hr. Data are representative of two experiments run with three
individual samples; values represent the average ± SEM.
(E) A schematic of the inhibition of RIG-I signaling by linear ubiquitinated NEMO-mediated dissociation of the MAVS-TRAF3 complex.
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Linear Ubiquitinated NEMO Inhibits RIG-I SignalingLys63 chain from TRAF3, leading to its dissociation from TBK1
(Kayagaki et al., 2007).
These multiple nonredundant mechanisms of regulation of the
early antiviral response illustrate the requirement to maintain
appropriate regulatory homeostasis of the IFN pathway. Many
examples of the pathological consequences of dysregulation
of antiviral and inflammatory responses to pathogens exist.
The IFIH1 gene encoding Mda5 has been associated with
several types of autoimmune diseases such as type I diabetes,
Grave’s disease, and systemic lupus erythematous (SLE)
(Gateva et al., 2009; Smyth et al., 2006; Sutherland et al.,
2007). Activation of TLR7 and TLR9 on B cells and plasmacytoid
dendritic cells by self-nucleic acid is also crucial step in SLE
pathogenesis (Barrat and Coffman, 2008; Guiducci et al.,
2010). Production of TLR-mediated antinuclear antibodies and
type I interferon correlated with the severity of the disease (Ban-Cell Hoschereau and Pascual, 2006; Hahn, 1998). Perhaps unsurpris-
ingly, IRF7, a downstream effector of both RLR and TLR
signaling, has been linked to SLE onset (Xu et al., 2012). Lastly,
the involvement of the ubiquitin regulatory TRIM proteins in
various autoimmune and autoinflammatory disorders (including
multiple sclerosis, SLE, and Sjo¨gren’s syndrome) has been es-
tablished (Jefferies et al., 2011). How these negative regulatory
mechanisms are disrupted in various pathological states is
critical to the understanding of conditions involving chronic
antiviral and inflammatory responses.EXPERIMENTAL PROCEDURES
Plasmid Construction
Plasmids encoding GFP-MAVS, MYC-MAVS, GFP-DRIG-I, GFP-TBK1, GFP-
IRF-3(5D), ISRE-luciferase, pRLTK, FLAG-NEMO, FLAG-TRAF3, HA-Ub,t & Microbe 12, 211–222, August 16, 2012 ª2012 Elsevier Inc. 219
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Linear Ubiquitinated NEMO Inhibits RIG-I SignalingMYC-HOIP, and HA-HOIL-1 were previously described (Paz et al., 2009, 2011;
Tokunaga et al., 2009; Zhao et al., 2007). The Mda5 expression plasmid was
a gift from I. Julkunen (Sire´n et al., 2006). To generate GFP-Mda5 expression
plasmid, Mda5 cDNA was amplified by PCR from Mda5 expression plasmid
and cloned into pEGFPc1. Flag NEMO was inserted into pMSCV puro vector
(Clontech). FLAG-NEMO-Ub1, Ub2, and Ub4 were constructed by adding
one ubiquitin or tandem linkage of two or four ubiquitin moieties at the C
terminus of Flag NEMO. To generate S-NEMO, S-NEMO-Ub1, and S-
NEMO-Ub2 expression plasmids, the cDNA encoding S-NEMO, S-NEMO-
Ub1, and S-NEMO-Ub2 were cloned into pTriEX-4 Neo vector (Novagen).
Cell Culture, Transfection, and Luciferase Assay
WT MEFs and cpdm MEFs from mice deficient in SHARPIN have been
described (Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011).
HEK293 and MEFs were grown in DMEM media (Wisent) supplemented with
10% (vol/vol) FBS, L-glutamine, and antibiotics (Wisent). For luciferase assays,
MEF cells grown to subconfluency in DMEM (Wisent) supplemented with 10%
(vol/vol) FBS, L-glutamine, and antibiotics were transfected with 200 ng of
pRLTK reporter (renilla luciferase; internal control); 200 ng of ISRE-Luc, NF-
kB-Luc, IFNB-pGL3, or IFNA4-pGL3 luciferase reporter (firefly luciferase;
experimental reporter); and 200 ng of MAVS, DRIG-I, TRIF, TBK1, or IRF-
3(5D) expression plasmid using Lipofectamine 2000 according to the
manufacturer’s instructions (Invitrogen). HEK293 cells were transfected with
50 ng of PRLTK reporter, 100 ng of ISRE-Luc or NF-kB-Luc reporter, expres-
sion-plasmid-encoding Mda5 (200 ng), DRIG-I (200 ng), MAVS (50 ng), TRIF
(50 ng), TBK1 (50 ng), or IRF-3 (5D) (50 ng), together with 400 ng of empty
vector, LUBAC (HOIL-1 and HOIP), NEMO-Ub1, NEMO-Ub2, or NEMO-Ub4
expression plasmid by the calcium phosphate transfection method (Zhao
et al., 2007). At 24 hr after transfection, luciferase activity was measured
with a dual-luciferase reporter assay system according to the manufacturer’s
instructions (Promega). Some cells were treated with SeV (40 hemagglutina-
tion units per ml, Charles River).
Generation of Flag-NEMO, Flag-NEMO-Ub1, and Flag-NEMO-Ub2
Expressing Cell Lines
Plasmids Flag pMSCV puro, Flag-NEMO pMSCV puro, Flag-NEMO-Ub1
pMSCV puro, and Flag-NEMO-Ub2 pMSCV puro were introduced into
HEK293 cells by the calcium phosphate method. Cells were selected begin-
ning at 48 hr for approximately 2 weeks in DMEM containing 10% FBS,
L-glutamine, antibiotics, and 2 mg/ml puromycin (Sigma).
Short-Interfering RNA
For siRNA experiments, siRNA-targeting human HOIL-1L (RBCK1) (Smart-
pool, Dharmacon), and control nontargeting siRNA pool (Dharmacon) were
transfected in A549 or HEK293 cells using Lipofectamine 2000 according to
the manufacturer’s instructions (Invitrogen). Forty-eight hours after transfec-
tion, A549 cells were infected with SeV and harvested 4, 8, and 12 hr later.
Luciferase reporter gene assays were performed on siRNA control and siRNA
HOIL-1L HEK293 cells, as described above.
Immunoblot Analysis
Whole-cell lysates (40 mg) were separated by 10% SDS-PAGE. After electro-
phoresis, proteins were transferred for 1 hr at 4C to nitrocellulose
membranes (0.45 m, Bio-Rad) in a buffer containing 30 mM Tris, 200 mM
glycine, and 20% (vol/vol) methanol. Membranes were blocked for 1 hr at
25C in 5% (WT/vol) dried milk in PBS and 0.1% (vol/vol) Tween-20
(PBST) and then were probed with antibody to the Flag-tag (anti Flag [M2];
Sigma Aldrich), VSV whole virus antisera, SeV antisera, anti NEMO (DA10-
12; Cell Signaling), anti-HOIL-1L (RBCK1, a gift from H.-B. Shu, Wuhan
University) (Zhang et al., 2008a) antibody to IRF-3 phosphorylated at
Ser396 (EMD-Millipore), anti-MYC (Sigma), anti-HA (Sigma), anti-SHARPIN
(Ikeda et al., 2011), anti-RIG-I (EMD-Millipore), anti-TRAF3(Santa Cruz
Biotechnology), and anti-actin (EMD-Millipore) at a dilution of 1 mg/ml in
5% (WT/vol) milk in PBS. After three 10 min washes with 0.1% (vol/vol)
Tween-20 in PBS, membranes were incubated for 1 hr with horseradish
peroxidase-conjugated goat anti-rabbit or anti-mouse (Amersham) at a dilu-
tion of 1:3000 in blocking solution. The reaction was then visualized with an
enhanced chemiluminescence detection system as recommended by the220 Cell Host & Microbe 12, 211–222, August 16, 2012 ª2012 Elsevimanufacturer (PerkinElmer). Densitometry analysis was performed using
ImageJ software (NIH Windows version).
Protein-Protein Interaction Analysis
For S-tag precipitation, 500 mg of whole-cell lysate was incubated with 90 ml
bed volume of S-protein agarose (Novagen), rotating at 4C for 6 hr, then
washed 3 times with 1 ml lysis buffer (20mM Tris [pH 7.5], 150mM NaCl,
10% glycerol, 1% triton, 1 mM DTT, 1 mM PMSF, 40 mM b-glycerol phos-
phate, 1 mM sodium orthovanadate, Protease inhibitor, 5 mM sodium fluo-
ride, 10 mM N-ethylmaleimide). Washed beads were eluted by resuspension
in 45 ml Laemmli Sample Buffer with b-mercaptoethanol, followed by boiling
for 10 min. Eluates were electrophoresed in a 10% SDS polyacrylamide gel
and transferred onto nitrocellulose blot. The transferred blots were auto-
claved for 30 min in water then 15 min dry. Blots were blocked for 1 hr at
room temperature in 20% heat inactivated bovine calf serum-TBS-0.45%
Tween then processed for immunoblot analysis with the appropriate anti-
bodies, as described above.
For endogenous immunoprecipitation experiments in MEFs, cells were
harvested and lysed in immunoprecipitation lysis buffer (20 mM Tris [pH
7.0], 250 mM NaCl, 3 mM EDTA, 3 mM EGTA, 0.5% NP-40, 1 mM DTT,
1 mM PMSF, 40 mM b-glycerol phosphate, 1 mM sodium orthovanadate,
Protease inhibitor, 5 mM sodium fluoride, 10 mM N-ethylmaleimide). To
detect the ubiquitinated form of NEMO, lysed cells were incubated at 95C
for 30 min in 1% SDS in immunoprecipitation lysis buffer and then diluted
to 0.1% SDS with immunoprecipitation lysis buffer. NEMO was immunopre-
cipitated using an antibody against NEMO (BD pharmingen) at 4C for 2 hr,
followed by incubation with protein A/G-PLUS agarose beads overnight.
MAVS was immunoprecipitated using an antibody against MAVS (EMD
Millipore 06-1043); TRAF3 was immunoprecipitated using an antibody
against TRAF3 (Santa-Cruz, sc-6933). Immunoprecipitates were resolved
on 10% SDS-PAGE and processed for immunoblot analysis with the appro-
priate antibodies, as described above.
Virus Production, Quantification, and Infection
Recombinant VSV-GFP, which harbors the methionine 51 deletion in the
matrix protein-coding sequence (Stojdl et al., 2003), was kindly provided by
J. Bell (Ottawa Health Research Institute). Virus stocks were grown in Vero
cells, concentrated from cell-free supernatants by centrifugation, and titrated
by standard plaque assay. Cells were infected with VSV in a small volume of
medium without FBS for 1 hr at 37C; cells were then incubated in complete
medium for the indicated period of time prior to analysis. To evaluate MEF
infectivity, cells were infected at different MOI with VSV-GFP. GFP fluores-
cence intensity was measured by flow cytometry using a FACSCalibur (BD
Biosciences) and data were analyzed with FCS Express 3 (De Novo Software).
IFNa, IFNb, and IL6 in cell supernatants were quantified by ELISA (PBL Inter-
feron Source).
Quantitative Real-Time PCR
DNase-treated total RNA from MEFs was prepared using the RNeasy kit
(QIAGEN). RNA concentration was determined by absorption at 260 nm,
and RNA quality was ensured by a 260/280 ratio R2.0. Total RNA was
reverse transcribed with 100 U of Superscript II Plus RNase H reverse tran-
scriptase using oligo AnCT primers (GIBCO BRL Life Technologies). qPCR
assays were performed using the SYBR Green I on a Light Cycler apparatus
(Roche Diagnostics). Murine primers sequences used in this study are as
follows: IRF-7 Forward: 50-AAG CAT TTC GGT CGT AGG G-30; IRF-7
Reverse: 50-GAG CCC AGC ATT TTC TCT TG-30; DDX58 (RIG-I) Forward:
50-AAG CAA GGC TGA TGA GGA TG-30; DDX58 (RIG-I) Reverse: 50-CTC
GCA ATG TTG TAC CCA AG-30; OAS1 Forward: 50-GGC TGA AGA GGC
TGA TGT GT-30; OAS1 Reverse: 50-ACC AAG CGT GTG TTC TTT CC-30;
IL6 Forward: 50-CCA CGG CCT TCC CTA CTT C-30; IL6 Reverse: 50-TTG
GGA GTG GTA TCC TCT GTG A-30; GAPDH Forward: 50-GGG AAG CCC
ATC ACC ATC T-30; GAPDH Reverse: 50-CGG CCT CAC CCC ATT TG-30.
PCR efficiency results were obtained from duplicate measurements of two
individual cDNA samples. Experiments were performed at least twice. All
data are presented as a relative quantification, based on the relative expres-
sion of target genes versus GAPDH as reference gene and analyzed using
Prism 5 software.er Inc.
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